Skip to main content
Open Access Publications from the University of California

Catatonia Associated with Initiating Paliperidone Treatment

Creative Commons 'BY-NC' version 4.0 license

We present a case of catatonia, which occurred shortly after starting a new antipsychotic, paliperidone, an active metabolite of risperidone. Catatonia may be caused by a variety of conditions, including metabolic, neurologic, psychiatric and toxic processes. Interestingly, risperidone, which has been thought to cause several cases of catatonia, has also been recommended as a potential treatment. We discuss potential mechanisms for causes of drug-induced catatonia as well as potential treatment options. [West J Emerg Med. 2010; 11(2):186-188.]

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View